Abstract:Biologically active proteins/regions without stable structure (i.e., intrinsically disordered proteins and regions (IDPs and IDRs)) are commonly found in all proteomes. They have a unique functional repertoire that complements the functionalities of ordered proteins and domains. IDPs/IDRs are multifunctional promiscuous binders capable of folding at interaction with specific binding partners on a template- or context-dependent manner, many of which undergo liquid-liquid phase separation, leading to the formation of membrane-less organelles and biomolecular condensates. Many of them are frequently related to the pathogenesis of various human diseases. All this defines IDPs/IDRs as attractive targets for the development of novel drugs. However, their lack of unique structures, multifunctionality, binding promiscuity, and involvement in unusual modes of action preclude direct use of traditional structure-based drug design approaches for targeting IDPs/IDRs, and make disorder-based drug discovery for these "protein clouds" challenging. Despite all these complexities there is continuing progress in the design of small molecules affecting IDPs/IDRs. This article describes the major structural features of IDPs/IDRs and the peculiarities of the disorder-based functionality. It also discusses the roles of IDPs/IDRs in various pathologies, and shows why the approaches elaborated for finding drugs targeting ordered proteins cannot be directly used for the intrinsic disorder-based drug design, and introduces some novel methodologies suitable for these purposes. Finally, it emphasizes that regardless of their multifunctionality, binding promiscuity, lack of unique structures, and highly dynamic nature, "protein clouds" are principally druggable. Significance Statement Intrinsically disordered proteins and regions are highly abundant in nature, have multiple important biological functions, are commonly involved in the pathogenesis of a multitude of human diseases, and are therefore considered as very attractive drug targets. Although dealing with these unstructured multifunctional protein/regions is a challenging task, multiple innovative approaches have been designed to target them by small molecules.

Targeting intrinsically disordered proteins at the edge of chaos

Rational Drug Design Targeting Intrinsically Disordered Proteins

Binding Cavities and Druggability of Intrinsically Disordered Proteins.

Conservation of Potentially Druggable Cavities in Intrinsically Disordered Proteins

Ligand clouds around protein clouds: a scenario of ligand binding with intrinsically disordered proteins.

How to drug a cloud? Targeting intrinsically disordered proteins

Design of intrinsically disordered protein variants with diverse structural properties

Advantages of Proteins Being Disordered

Proteasome activation: A novel strategy for targeting undruggable intrinsically disordered proteins

Structure-Based Inhibitor Design for the Intrinsically Disordered Protein C-Myc

An Overview of Predictors for Intrinsically Disordered Proteins over 2010–2014

Intrinsically Disordered Proteins at the Nano-scale

Molecular Docking of Intrinsically Disordered Proteins: Challenges and Strategies

Do Intrinsically Disordered Proteins Possess High Specificity in Proteinprotein Interactions?

Smoothing molecular interactions: The “kinetic buffer” effect of intrinsically disordered proteins

Design of functional intrinsically disordered proteins

Computational Prediction of Protein Intrinsically Disordered Region Related Interactions and Functions

How Intrinsically Disordered Proteins Modulate Biomolecular Condensates

Computational Methods to Investigate Intrinsically Disordered Proteins and their Complexes

Computational Strategy for Intrinsically Disordered Protein Ligand Design Leads to the Discovery of P53 Transactivation Domain I Binding Compounds That Activate the P53 Pathway

Combined Prediction and Design Reveals the Target Recognition Mechanism of an Intrinsically Disordered Protein Interaction Domain.